These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
139 related articles for article (PubMed ID: 6471419)
1. [Uptake of radioactive precursors for the evaluation of sensitivity of anticancer drugs against cancer cells]. Ichihashi H; Kondo T Gan No Rinsho; 1984 Jul; 30(9 Suppl):1130-8. PubMed ID: 6471419 [TBL] [Abstract][Full Text] [Related]
2. [In vitro method determining sensitivity of anticancer agents by incorporation of radioactive precursors]. Sakakibara S Nihon Geka Gakkai Zasshi; 1983 Jan; 84(1):8-19. PubMed ID: 6425633 [TBL] [Abstract][Full Text] [Related]
3. Application of radioactive precursors for the evaluation of sensitivity of cancer cells to anticancer drugs. Ichihashi H; Kondo T; Sakakibara S; Akiyama S; Watanabe T Oncology; 1984; 41(2):88-95. PubMed ID: 6709278 [TBL] [Abstract][Full Text] [Related]
4. [In vitro chemosensitivity test of human solid cancer: 3H-thymidine uptake inhibition test]. Hanatani Y; Kubota T; Ishibiki K; Abe O Gan No Rinsho; 1984 Jul; 30(9 Suppl):1123-9. PubMed ID: 6471418 [TBL] [Abstract][Full Text] [Related]
5. Assessment of in vitro drug sensitivity of human tumor cells using [3H]thymidine incorporation in a modified human tumor stem cell assay. Friedman HM; Glaubiger DL Cancer Res; 1982 Nov; 42(11):4683-9. PubMed ID: 7127304 [TBL] [Abstract][Full Text] [Related]
6. [Sensitivity test of anticancer agents using human tumor xenografts in nude mice with special reference on correlation between clinical effects and chemotherapy]. Nosoh Y; Yoshinaka K; Nishimawari K; Hirono M; Tani T; Niimoto M; Hattori T Gan No Rinsho; 1984 Jul; 30(9 Suppl):1181-5. PubMed ID: 6433069 [TBL] [Abstract][Full Text] [Related]
7. Use of tritiated nucleotide incorporation for prediction of sensitivity of tumors to cytostatic agents. Volm M Behring Inst Mitt; 1984 May; (74):273-84. PubMed ID: 6383325 [TBL] [Abstract][Full Text] [Related]
8. Different sensitivity to antibiotics of the established intermitent in vivo--in vitro tumor cell lines in comparison with the primary cultures. Fusková A; Fuska J; Ivanitskaya LP; Makukho LV Neoplasma; 1977; 24():239-42. PubMed ID: 865652 [TBL] [Abstract][Full Text] [Related]
9. [Application of nude mouse-human cancer xenograft system for sensitivity test of anticancer drugs]. Fujita M; Taguchi T Gan To Kagaku Ryoho; 1982 Apr; 9(4):606-15. PubMed ID: 7184418 [TBL] [Abstract][Full Text] [Related]
10. Inhibition of mitosis and anticancer activity against experimental neoplasms by ethyl 5-amino-1,2-dihydro-3-[(N-methylanilino)methyl]-pyrido[3,4-b]pyrazin-7-ylcarbamate (NSC 181928). Wheeler GP; Bowdon BJ; Werline JA; Adamson DJ; Temple CG Cancer Res; 1982 Mar; 42(3):791-8. PubMed ID: 7059977 [TBL] [Abstract][Full Text] [Related]
11. Novel phosphonium salts display in vitro and in vivo cytotoxic activity against human ovarian cancer cell lines. Manetta A; Gamboa G; Nasseri A; Podnos YD; Emma D; Dorion G; Rawlings L; Carpenter PM; Bustamante A; Patel J; Rideout D Gynecol Oncol; 1996 Feb; 60(2):203-12. PubMed ID: 8631539 [TBL] [Abstract][Full Text] [Related]
12. [Clinical studies on a rapid screening assay for anticancer agents with nude mice and isotopic evaluation]. Nosoh Y; Nishiyama M; Yamaguchi M; Hirabayashi N; Toge T; Niimoto M; Hattori T Gan To Kagaku Ryoho; 1986 Apr; 13(4 Pt 2):1221-6. PubMed ID: 3729445 [TBL] [Abstract][Full Text] [Related]
13. [Assay of anti-cancer drug sensitivity of cells from human tumors. Detection of cell viability with radioisotope (author's transl)]. Ishii M; Yamamuro T; Takeda T Nihon Seikeigeka Gakkai Zasshi; 1982 Apr; 56(4):293-304. PubMed ID: 7097093 [TBL] [Abstract][Full Text] [Related]
14. [Chemosensitivity testing for human ovarian cancer on in vitro colony assay]. Inoue K Gan No Rinsho; 1984 Jul; 30(9 Suppl):1146-51. PubMed ID: 6471421 [TBL] [Abstract][Full Text] [Related]
15. Antitumor activity of troxacitabine (Troxatyl) against anthracycline-resistant human xenografts. Gourdeau H; Genne P; Kadhim S; Bibeau L; Duchamp O; Ouellet F; deMuys JM; Bouffard DY; Attardo G Cancer Chemother Pharmacol; 2002 Dec; 50(6):490-6. PubMed ID: 12451476 [TBL] [Abstract][Full Text] [Related]
16. Overcoming drug-resistant cancer by a newly developed copper chelate through host-protective cytokine-mediated apoptosis. Mookerjee A; Mookerjee Basu J; Dutta P; Majumder S; Bhattacharyya S; Biswas J; Pal S; Mukherjee P; Raha S; Baral RN; Das T; Efferth T; Sa G; Roy S; Choudhuri SK Clin Cancer Res; 2006 Jul; 12(14 Pt 1):4339-49. PubMed ID: 16857809 [TBL] [Abstract][Full Text] [Related]
17. [Effect of anticancer drugs on in vitro survival of cell lines derived from various gynecologic tumors (author's transl)]. Sekiya S; Takamizawa H Acta Obstet Gynaecol Jpn; 1981 Mar; 33(3):373-6. PubMed ID: 6163305 [TBL] [Abstract][Full Text] [Related]
18. Antitumor organometallics. II. Inhibitory effects of two diphenyl-antimony (III) dithiophosphorus derivatives on in vitro and in vivo Ehrlich ascites tumor. Socaciu C; Bara A; Silvestru C; Haiduc I In Vivo; 1991; 5(4):425-8. PubMed ID: 1667268 [TBL] [Abstract][Full Text] [Related]
19. (R,R)-2,2'-[1,2-ethanediylbis[imino(1-methyl-2,1-ethanediyl)]]- bis[5-nitro-1H-benz[de]isoquinoline-1,3-(2H)-dione] dimethanesulfonate (DMP 840), a novel bis-naphthalimide with potent nonselective tumoricidal activity in vitro. Kirshenbaum MR; Chen SF; Behrens CH; Papp LM; Stafford MM; Sun JH; Behrens DL; Fredericks JR; Polkus ST; Sipple P Cancer Res; 1994 Apr; 54(8):2199-206. PubMed ID: 8174127 [TBL] [Abstract][Full Text] [Related]
20. A methodological approach to the prediction of anticancer drug effect in humans. Durkin WJ; Ghanta VK; Balch CM; Davis DW; Hiramoto RN Cancer Res; 1979 Feb; 39(2 Pt 1):402-7. PubMed ID: 761212 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]